Anaplastic lymphoma kinase (ALK): A potential oncogenic driver in triple-negative breast cancer?

1067 Background: TNBC, a molecularly heterogeneous subset of breast cancer, has an aggressive clinical course and no established targets for therapy. Wild-type ALK gene amplification by fluorescenc...